Parexel Publishes Findings on Making Clinical Research More Accessible for Gender-Diverse Populations
Parexel has published findings and recommendations for making clinical research more accessible and welcoming for transgender and nonbinary people.
While there are nearly 1.6 million transgender people in the US alone, of the thousands interventional clinical trial results published on PubMed from 2018 to 2022, Parexel notes less than one percent included participation of transgender and nonbinary patients. Many have deep-rooted reservations about healthcare and worry the risks of participating in a clinical trial would outweigh its benefits.
Through collaborating with partners and their patient advisory council and extensive research, Parexel identified five roadblocks to participation and eight solutions for designing more equitable clinical trials for transgender and nonbinary patients.
Download the study here.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
